Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.CytRx Receives Letter From FDA
CytRx has received letter from the FDA regarding the arimoclomol phase IIb clinical trial. Under its guidelines, the FDA will have 30 days following CytRx’s planned protocol submission
CytRx has received letter from the FDA regarding the arimoclomol phase IIb clinical trial. Under its guidelines, the FDA will have 30 days following CytRx’s planned protocol submission
Cell Biosciences and Alpha Innotech have entered into an agreement, by which Alpha Innotech will be acquired by Cell Biosciences for $1.50 per share, or approximately $17.9m in
LigoCyte Pharmaceuticals (LigoCyte) has initiated its third human clinical trial of its norovirus vaccine. The phase I/II study will assess safety and immunogenicity associated with LigoCyte’s investigational, nasally-delivered,
Aeolus Pharmaceuticals (Aeolus) has initiated a study to confirm the efficacy of AEOL 10150 as a countermeasure to nuclear and radiological exposure in non-human primates. AEOL 10150 has
eBioscience Corporation, a provider of cell analysis reagents, has acquired NatuTec GmbH, a distributor of biological research reagents located in Frankfurt am Main, Germany. The NatuTec acquisition is
Expanded dermatology division of Valeant Pharmaceuticals North America, Coria Laboratories has provided update on Acanya Gel (clindamycin phosphate 1.2% and BPO 2.5%). The company said the gel is
Osiris Therapeutics has announced preliminary results for two phase III trials evaluating Prochymal for the treatment of acute graft versus host disease (GvHD). Prochymal showed significant improvements in
Peregrine Pharmaceuticals has reported completion of patient enrollment in its phase II trial evaluating bavituximab in combination with carboplatin and paclitaxel in advanced breast cancer patients. The trial’s
Albemarle has announced the execution of a Memorandum of Understanding (MOU) to form a strategic alliance with MeadWestvaco Specialty Chemicals. The alliance will secure a domestic supply of
MeadWestvaco (MWV) has reported the launch of Med-Easy, the company’s medication packaging. Med-Easy is scheduled to launch this September in Europe and will be available for Rx and